MARGONI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.580
EU - Europa 359
AS - Asia 308
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.251
Nazione #
US - Stati Uniti d'America 1.580
IT - Italia 187
SG - Singapore 150
CN - Cina 137
FR - Francia 39
SE - Svezia 34
FI - Finlandia 26
GB - Regno Unito 23
DE - Germania 13
NL - Olanda 9
RU - Federazione Russa 6
IE - Irlanda 5
UA - Ucraina 5
HK - Hong Kong 4
IN - India 4
JP - Giappone 4
CH - Svizzera 3
DK - Danimarca 3
KR - Corea 3
ES - Italia 2
MK - Macedonia 2
TR - Turchia 2
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
BR - Brasile 1
EC - Ecuador 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 2.251
Città #
Fairfield 262
Chandler 168
Ashburn 139
Woodbridge 135
Santa Clara 128
Singapore 118
Cambridge 97
Houston 88
Seattle 81
Wilmington 53
Boardman 47
Milan 44
Ann Arbor 42
Beijing 39
Medford 27
Princeton 27
Roxbury 24
Helsinki 19
San Diego 18
Des Moines 17
Guangzhou 17
Padova 13
Paris 12
Shanghai 11
Nanjing 8
Rome 7
Cagliari 6
Lappeenranta 6
New York 6
Casatenovo 5
Castelfranco Veneto 5
Dublin 5
Florence 5
Kharkiv 5
Los Angeles 5
Norwalk 5
Amsterdam 4
Cotignola 4
London 4
Basel 3
Genoa 3
Gyeonggi-do 3
Hong Kong 3
Jinan 3
Ogden 3
Povegliano Veronese 3
Redwood City 3
Southwark 3
Albignasego 2
Altinordu 2
Atri 2
Bagheria 2
Bari 2
Birmingham 2
Bologna 2
Boston 2
Brescia 2
Changsha 2
Columbus 2
Cormano 2
Cosenza 2
Dallas 2
Haikou 2
Harada 2
Hebei 2
Islington 2
Jerez de la Frontera 2
Jīnd 2
Lipari 2
Monza 2
Noale 2
Preganziol 2
Prescot 2
San Giorgio delle Pertiche 2
Sassari 2
Skopje 2
Trento 2
Treviso 2
Valera Fratta 2
Vicenza 2
Vénissieux 2
Ariano Irpino 1
Atlanta 1
Baku 1
Brussels 1
Cafasse 1
Caldogno 1
Chicago 1
Chiswick 1
Dongguan 1
Este 1
Frankfurt am Main 1
Frosinone 1
Fumane 1
Fuyang 1
Glasgow 1
Hamad Town 1
Hamburg 1
Hangzhou 1
Hounslow 1
Totale 1.818
Nome #
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis 119
Ophthalmoplegic migraine: Could electroencephalogram still be a useful tool to better understand the pathogenetic mechanism? 108
A new Italian family with HTRA1 mutation associated with autosomal-dominant variant of CARASIL: Are we pointing towards a disease spectrum? 100
Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset. 98
Quantificazione del danno microstrutturale nella sclerosi multipla attraverso il rapporto delle sequenze pesate in T1 e T2: uno studio multicentrico 96
No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab 91
Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques 89
Isolated choroid plexus involvement in a case of granulomatosis with polyangiitis negative for antineutrophil cytoplasmic antibodies (ANCA) 87
Slowly Progressive Optic Perineuritis as the First Clinical Manifestation of Sarcoidosis 87
Early red nucleus atrophy in relapse-onset multiple sclerosis 80
Effects of disease modifying therapies on brain and grey matter atrophy in relapsing remitting multiple sclerosis 77
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 77
null 71
Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study 70
Hematoma of Meckel's cave: a rare possible symptomatic trigeminal neuralgia 69
Idiopathic hypertrophic cranial pachymeningitis as a rare cause of status epilepticus 66
Ophthalmoplegic migraine: could electroencephalogram still be a useful tool to better understand the pathogenetic mechanism? 60
A novel mutation in ABCD1 unveils different clinical phenotypes in a family with adrenoleukodystrophy 60
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 60
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis 59
Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imaging 58
Very late-onset recurrent myelitis in a patient diagnosed with antiphospholipid syndrome: A puzzle of autoimmunity 55
Ketogenic diet in migraine treatment: a brief but ancient history 53
Neurite orientation dispersion and density imaging discloses early changes in the normal-appearing white matter in paediatric multiple sclerosis 53
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic 52
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis 35
Selective Cerebellar Atrophy Associates with Depression and Fatigue in the Early Phases of Relapse-Onset Multiple Sclerosis 34
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 31
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre 30
Cerebellar pathology and disability worsening in relapsing‐remitting multiple sclerosis: a retrospective analysis from the CombiRx trial 28
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre 23
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 23
Influence of cardiorespiratory fitness and MRI measures of neuroinflammation on hippocampal volume in multiple sclerosis 20
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities 19
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers 18
null 18
Emerging Perspectives on MRI Application in Multiple Sclerosis: Moving from Pathophysiology to Clinical Practice 17
Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis 17
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 16
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 15
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 15
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis 12
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 10
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study 9
A Fully Automatic Method to Segment Choroid Plexuses in Multiple Sclerosis Using Conventional MRI Sequences 9
Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients 9
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 5
Totale 2.308
Categoria #
all - tutte 11.673
article - articoli 11.497
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020272 0 0 0 0 0 15 36 33 42 89 26 31
2020/2021358 13 50 12 28 45 16 8 45 45 43 43 10
2021/2022351 5 14 29 17 36 37 24 31 47 8 26 77
2022/2023340 54 30 14 35 48 48 2 27 45 13 17 7
2023/2024360 12 28 23 41 34 28 40 21 26 32 34 41
2024/2025444 9 87 71 40 209 28 0 0 0 0 0 0
Totale 2.308